Skip to content
10-K

Annual Report

CANCER CAPITAL CORP.

0001554795-24-000087

← back to feed
Filed
Apr 15, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 31, 2024 6.15M sh
Operating Cash Flow FY 2023 · Dec 31, 2023 −$8.9K
Operating Cash Flow restated FY 2023 · Dec 31, 2022 −$15.01K
Cash And Equivalents FY 2023 · Dec 31, 2023 $16.16K
Cash And Equivalents FY 2023 · Dec 31, 2022 $22.06K
Stockholders Equity FY 2023 · Dec 31, 2023 −$449.39K
Stockholders Equity FY 2023 · Dec 31, 2022 −$411.6K
Stockholders Equity FY 2023 · Dec 31, 2021 −$369.13K
Current Liabilities FY 2023 · Dec 31, 2023 $465.55K
Current Liabilities FY 2023 · Dec 31, 2022 $433.65K
Total Liabilities FY 2023 · Dec 31, 2023 $465.55K
Total Liabilities FY 2023 · Dec 31, 2022 $433.65K
Current Assets FY 2023 · Dec 31, 2023 $16.16K
Current Assets FY 2023 · Dec 31, 2022 $22.06K
Total Assets FY 2023 · Dec 31, 2023 $16.16K
Total Assets FY 2023 · Dec 31, 2022 $22.06K
Eps Basic FY 2023 · Dec 31, 2023 −$0.01
Eps Basic FY 2023 · Dec 31, 2022 −$0.01
Sga Expense FY 2023 · Dec 31, 2023 $14.9K
Sga Expense FY 2023 · Dec 31, 2022 $21.01K
Net Income FY 2023 · Dec 31, 2023 −$37.79K
Net Income FY 2023 · Dec 31, 2022 −$42.47K
Operating Income FY 2023 · Dec 31, 2023 −$14.9K
Operating Income FY 2023 · Dec 31, 2022 −$21.01K